CV Update_web banner 1.png

Course Director 

J. Brent Muhlestein, MD, FAHA, FACC


The purpose of this activity is to update primary care providers and cardiologists on the latest advances in relation to the diagnosis and management of cardiovascular disease. This is designed to provide new and important information regarding cardiovascular disease, the most common cause of morbidity and mortality in America. As with our previous conferences, we will concentrate on providing the primary care physician, nurse and pharmacist with the most up-to-date information regarding important cardiovascular problems commonly encountered in the primary care setting.


​Upon completion of this activity, participants should be able to:
  • Understand the most up-to-date guidelines regarding the diagnosis and management of acute coronary syndromes, including both STEMI and non-STEMI presentations.   They should also be able to understand the underlying pathophysiology related to those guidelines.
  • Appropriately manage their patients’ hyperlipidemia using both standard statins and also some of the newer evidence-based lipid lowering medications such as evolocumab, alirucumab and ezetimibe.  They will know how to best weigh the costs and benefits of the use of any or all of these drugs on an individual basis.
  • Appropriately manage their patients’ chronic heart failure using the most cost-effective, evidence-based strategies available.
  • Control their patients’ hypertension in a safe, cost-effective manner.  They will know when to use some of the expensive new antihypertensive medications, such as sacubatril and nebivolol, and upon what basis those decisions are justified.
  • More effectively interpret their patients’ ECGs in order to rapidly initiate the most appropriate therapy.
  • Understand the evolving uses and indications for transcatheter therapies for cardiac valvular disease.  This will include treatments for the aortic valve, mitral valve and tricuspid valve.
  • Determine the most appropriate treatments, whether medical or mechanical, for many of the major cardiac arrhythmias, including atrial fibrillation, supraventricular tachycardia, ventricular fibrillation and ventricular tachycardia.
  • Understand the potential and availability of targeted anti-inflammatory medicines that have been demonstrated to reduce cardiovascular risk.
  • Understand the intricacies of the use of dual antiplatelet therapy for the treatment of patients undergoing PCI, and make appropriate decisions, on an individual basis, regarding their use.
  • Understand appropriate guidelines based cardiovascular evaluations for patients scheduled for noncardiac surgery.  They will know when it is necessary to have a cardiology consult.  We will know whether or not cardiac stress testing prior to surgery is indicated.  They will know what to do with the results of the car all if performed.

Target Audience

Primary care providers, cardiologists, pharmacists, and nursing staff.


​​Time Title and Speaker​
7:00 AM​​​​ ​Registration and Breakfast
​7:30 AM ​Welcome and Introduction
J. Brent Muhlestein, MD, FAHA, FACC
7:40 AM​ State-of-the-Art Management of Chronic Systolic Heart Failure
Michael McCulloch, MD
​8:10 AM Modern Lipid Management: New Drugs, New Targets, New Hope
Kirk U. Knowlton, MD
​8:40 AM 2017 Update on Managing Acute Coronary Syndrome – Advice from a World Expert
Jeffrey L. Anderson, MD
9:10 AM​ Antihypertensive Therapy: Does it matter which drugs we use?
Nishant Sekaran, MD

9:40 AM​ ​Panel Discussion
Moderator: J. Brent Muhlestein, MD, FACC
10:00 AM​ Break​
​10:10 AM ​ECG Reading Pearls​
Frank G. Yanowitz, MD, FACC
​10:40 AM Trans-catheter Therapies for Valvular Heart Disease
Brian K. Whisenant, MD, FACC
​11:10 AM ​Modern Arrhythmia Management: Drugs, devices or both?
T. Jared Bunch, MD
​11:40 AM ​Panel Discussion
Moderator: Donald L. Lappé, MD
​12:00 PM​ ​Break and Box Lunch 
12:30 PM​ Targeted Anti-inflammatory Therapy for the Treatment of Atherosclerosis: Will anything work?​
J. Brent Muhlestein, MD, FAHA, FACC
​1:00 PM Antiplatelet Therapy Post PCI in ACS and non-ACS:  Which drugs and for how long?
J. Brent Muhlestein, MD, FAHA, FACC
​1:30 PM To Stress or Not to Stress: Perioperative risk evaluation for non-cardiac surgery
David B. Min, MD​
​2:00 PM ​Panel Discussion
Moderator: Kirk U. Knowlton, MD
​2:30 PM​ ​Adjourn and Program Evaluation 


There is no fee to attend the course, however, registration is required. To register for the course, click on the Register Now button below. 


Intermountain CME

801.442.3930 (office)
800.842.5498 (toll-free)
801.442.0480 (fax)


Intermountain Healthcare Continuing Medical Education is accredited by Accreditation Council of Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 
Intermountain Healthcare Continuing Medical Education designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Intermountain Healthcare CME is an approved provider of continuing nursing education by the Western Multi-State Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Arizona, Colorado, Idaho, Utah Nurses Associations are members of the Western Multi-State Division of the American Nurses Association.

This educational activity offers 6.16 nursing contact hours. Successful completion is attendance at each day’s presentations. Credit is awarded for the number of sessions fully attended.​

Intermountain Healthcare CME fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant of this program is in need of accommodation, please do not hesitate to call and/or write to the CME office in order to receive service. A request for accommodation can be made by calling (801) 442-3930. Reasonable prior notice is required.

Sponsored by Intermountain Healthcare Continuing Medical Education​


© 2018 Intermountain Healthcare, All rights reserved.